Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities

Area of Science:

• Cardiovascular Medicine
• Hematology
• Biophysics

Background:

• Cardiovascular diseases (CVD) cause significant global mortality, with stroke and myocardial infarction being primary contributors.
• Platelets play a crucial role in both hemostasis and pathological thrombosis, but current anti-platelet drugs struggle to differentiate between these processes, leading to bleeding complications.
• Pathological thrombus formation is driven by shear forces, which are significantly amplified in obstructed blood vessels compared to healthy ones.

Purpose of the Study:

• To review the influence of shear forces on thrombosis and platelet activation mechanisms.
• To summarize therapeutic strategies targeting shear-sensitive platelet activation and pathological thrombus growth.
• To highlight the von Willebrand Factor (VWF) as a key shear-sensitive protein in this context.

Main Methods:

• Review of existing literature on platelet function, thrombosis, and shear stress.
• Analysis of molecular mechanisms underlying shear-induced platelet activation.
• Summary of current and emerging therapeutic approaches for anti-thrombotic therapy.

Main Results:

• Shear forces are critical in driving platelet activation and aggregation during thrombosis.
• The microenvironment of pathological thrombi exhibits significantly higher shear stresses.
• The von Willebrand Factor (VWF) is a key mediator of shear-induced platelet aggregation.

Conclusions:

• Leveraging abnormal shear forces in the thrombus microenvironment offers a promising strategy for developing shear-selective anti-platelet therapies.
• Targeting shear-specific platelet aggregation and utilizing targeted drug delivery could lead to safer and more effective treatments for cardiovascular diseases.
• Developing therapies that decouple pathological platelet responses from physiological hemostasis is essential for improving patient outcomes.